Respiratory Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of bevacizumab (Zirabev) in patients with severe hypoxemic COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) [Phase 3]
A Phase 3 trial comparing methylprednisolone to dexamethasone in COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease [Phase 2]
A Phase 2 trial of otilimab in patients with severe pulmonary disease related to COVID-19 has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) [Phase 3]
Phase 3 trial update on hydroxychloroquine as chemoprophylaxis for healthcare workers exposed to COVID-19 patients; trial completed.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) [Phase 3]
Phase 3 trial completed evaluating hydroxychloroquine for severe COVID-19 pneumonia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection [Phase 2]
Phase 2 trial evaluating fibrinolytic therapy for acute respiratory distress syndrome associated with COVID-19 has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic [Phase 3]
A Phase 3 pragmatic randomized trial compared therapeutic anticoagulation to standard care for COVID-19, completed.
-
CLINICAL_TRIALS withdrawal · 2021-08-20Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of the SARS-CoV-2 mRNA vaccine CVnCoV in elderly vs younger adults was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 [Phase 2]
Phase 2 trial evaluating methylprednisolone for patients with severe acute respiratory syndrome related to SARS; completed.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19
A completed clinical trial evaluating ivermectin, aspirin, dexamethasone, and enoxaparin for severe COVID-19-related respiratory conditions …
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
A completed clinical trial investigating methylprednisolone for patients with severe acute respiratory syndrome due to coronavirus infection…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis [Phase 2]
Phase 2 clinical trial update evaluating tocilizumab for severe pneumonitis due to SARS-CoV-2 (COVID-19).
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS [Phase 3]
Phase 3 trial comparing streptokinase versus nebulized unfractionated heparin for severe acute respiratory distress syndrome has completed, …
-
CLINICAL_TRIALS research · 2018-02-26Clinical Trial Update: Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory Syndrome
This clinical trial update outlines a long-term, observational assessment of organ function in survivors of severe acute respiratory syndrom…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) [Phase 1]
A Phase I trial evaluating a vaccine for severe acute respiratory syndrome (SARS) in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Investigating Severe Acute Respiratory Syndrome (SARS)
This entry reports a completed clinical trial investigating Severe Acute Respiratory Syndrome (SARS) under NIAID. The snippet provides no de…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Collection of Convalescent SARS Plasma by Apheresis
The trial update reports that collection of convalescent SARS plasma by apheresis has been completed under the NIAID SARS program.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
The clinical trial evaluating treatment of Severe Acute Respiratory Syndrome (SARS) sponsored by NIAID has been withdrawn.
-
CLINICAL_TRIALS research · 2013-08-22Clinical Trial Update: A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome [NA]
This document provides an update on a multi-centre, double-blind, randomized, placebo-controlled trial evaluating the combination of lopinav…
-
CLINICAL_TRIALS withdrawal · 2013-04-29Clinical Trial Update: SARS Survivor Evaluations
A clinical trial evaluating SARS survivors (SARS-CoV) has been withdrawn by its sponsor.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers [Phase 2]
A Phase 2 study of Alferon LDO (low-dose oral interferon alfa-N3) in healthy volunteers was completed to assess safety in the context of Sev…
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study [Phase 1]
A Phase I dose-escalation study of a SARS-CoV recombinant S protein vaccine, with and without an adjuvant, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-10Clinical Trial Update: The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes [NA]
This clinical trial investigating the interaction between severe acute respiratory syndrome viral proteins and monocytes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-03Clinical Trial Update: SARS Coronavirus Vaccine (SARS-CoV) [Phase 1]
A Phase 1 SARS-CoV vaccine trial has been withdrawn.